Back to Journals » OncoTargets and Therapy » Volume 11

A comparison of fulvestrant plus a targeted agent with fulvestrant alone in hormone receptor-positive advanced breast cancer that progressed on prior endocrine therapy: a meta-analysis

Total article views   HTML views PDF downloads Totals
7,810 Dovepress* 6,718+ 877 7,595
PubMed Central* 1,092 258 1,350
Totals 7,810 1,135 8,945
*Since 27 November 2018

View citations on PubMed Central and Google Scholar